<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-05-23">May 23, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Johannes</forename><forename type="middle">W</forename><surname>Dietrich</surname></persName>
							<email>johannes.dietrich@ruhr-uni-bochum.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Endocrinology and Diabetes</orgName>
								<orgName type="institution">Medical Hospital I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patrick</forename><surname>Müller</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology and Angiology</orgName>
								<orgName type="institution">Medical Hospital II</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Heart Center Bad Neustadt</orgName>
								<orgName type="department" key="dep2">Clinic for Interventional Electrophysiology</orgName>
								<address>
									<settlement>Bad Neustadt an der Saale</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fabian</forename><surname>Schiedat</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology and Angiology</orgName>
								<orgName type="institution">Medical Hospital II</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Markus</forename><surname>Schlömicher</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiac Surgery</orgName>
								<orgName type="institution" key="instit1">Bergmannsheil University Hospitals</orgName>
								<orgName type="institution" key="instit2">Ruhr University of Bochum</orgName>
								<address>
									<settlement>Bochum</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Justus</forename><surname>Strauch</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiac Surgery</orgName>
								<orgName type="institution" key="instit1">Bergmannsheil University Hospitals</orgName>
								<orgName type="institution" key="instit2">Ruhr University of Bochum</orgName>
								<address>
									<settlement>Bochum</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Apostolos</forename><surname>Chatzitomaris</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Endocrinology and Diabetes</orgName>
								<orgName type="institution">Medical Hospital I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Harald</forename><forename type="middle">H</forename><surname>Klein</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Endocrinology and Diabetes</orgName>
								<orgName type="institution">Medical Hospital I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Mügge</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology and Angiology</orgName>
								<orgName type="institution">Medical Hospital II</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Josef</forename><surname>Köhrle</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institut für Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eddy</forename><surname>Rijntjes</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institut für Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ina</forename><surname>Lehmphul</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institut für Experimentelle Endokrinologie</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Department of Endocrinology and Diabetes</orgName>
								<orgName type="institution" key="instit1">Medical Hospital I Bergmannsheil University Hospitals</orgName>
								<orgName type="institution" key="instit2">Ruhr University of Bochum</orgName>
								<address>
									<addrLine>Bürkle-de-la-Camp-Platz 1</addrLine>
									<postCode>DE-44789</postCode>
									<settlement>Bochum</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-05-23">May 23, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">C473165524FDE340A0F6CA7BDD624E6A</idno>
					<idno type="DOI">10.1159/000381543</idno>
					<note type="submission">Received: December 8, 2014 Accepted after revision: March 10, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>3,5-Diiodothyronine</term>
					<term>Reverse triiodothyronine</term>
					<term>Nonthyroidal illness syndrome</term>
					<term>TACITUS</term>
					<term>Atrial fibrillation</term>
					<term>Thyroid hormone</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Results: Seven of 17 patients who developed POAF demonstrated nonthyroidal illness syndrome (NTIS; defined as low T 3 and/or low T 4 syndrome), compared to 2 of 22 (p &lt; 0.05) patients who maintained sinus rhythm.</s><s>In patients with POAF, serum FT 3 concentrations were significantly decreased, but still within their reference ranges.</s><s>3,5-T 2 concentrations directly correlated with rT 3 concentrations and inversely correlated with FT 3 concentrations.</s><s>Furthermore, 3,5-T 2 concentrations were significantly elevated in patients with NTIS and in subjects who eventually developed POAF.</s><s>In multivariable logistic regression FT 3 , 3,5-T 2 , total atrial conduction time, left atrial volume index and Fas ligand were independent predictors of POAF.</s><s>Conclusion: This study confirms reduced FT 3 concentrations in patients with POAF and is the first to report on elevated 3,5-T 2 concentrations in cardiac NTIS.</s><s>The pathogenesis of NTIS therefore seems to involve more differentiated allostatic mechanisms.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>More than 70% of critically ill patients develop a constellation that is marked by reduced concentrations of total (T) and free (F) 3,3 ′ ,5-triiodo-L -thyronine (T 3 , low T 3 syndrome), impaired binding of thyroid hormones (TH) to their plasma proteins and, especially in chronic illness, by thyrotropic adaptation, i.e. diminished thyrotropin (TSH)-release despite decreased or low normal free thyroxine (FT 4 ) concentrations <ref type="bibr">[1,</ref><ref type="bibr" target="#b1">2]</ref> .</s><s>This condition is described as nonthyroidal illness syndrome (NTIS), euthyroid sick syndrome or TACITUS (thyroid allostasis in critical illness, tumors, uremia and starvation) and is accompanied by increased mortality and morbidity <ref type="bibr">[3,</ref><ref type="bibr" target="#b3">4]</ref> .</s><s>Several trials have demonstrated improved surrogate parameters after substitution therapy with T 3 in NTIS <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref> .</s><s>It could not be proven, however, that therapy with T 4 or T 3 ameliorates the overall outcome of affected patients <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref> .</s><s>Today it is still controversial as to whether NTIS represents a form of central hypothyroidism requiring treatment, whether it is simply associated with or results from severe illness, or if it represents an allostatic mechanism that is beneficial by reducing the demand for oxygen, energy and glutathione and by preventing the development of thyroid storm <ref type="bibr">[3,</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref> .</s><s>Results from clinical trials and animal experiments suggest possible favorable effects of TACITUS to be restricted to its acute phase, while chronic NTIS could represent a maladaptive response <ref type="bibr">[1]</ref> .</s><s>Of note, up to a third of noncritically ill hospitalized patients may also demonstrate milder forms of NTIS <ref type="bibr" target="#b11">[12]</ref> .</s></p><p><s>Iodothyronines have strong effects on cardiac function, including heart rhythm <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref> .</s><s>Congestive heart failure and atrial fibrillation (AF) are classical consequences of thyrotoxicosis included in two scoring systems for estimating the probability of thyroid storm <ref type="bibr" target="#b15">[16]</ref> .</s><s>Even subclinical hyperthyroidism is associated with increased risk for AF <ref type="bibr" target="#b16">[17]</ref> and a prolonged total atrial conduction time (TACT) <ref type="bibr" target="#b17">[18]</ref> , an independent predictor of AF <ref type="bibr" target="#b18">[19]</ref> .</s></p><p><s>However, AF may also occur after cardiac surgery.</s><s>Postoperative AF (POAF) contributes significantly to increased morbidity, mortality and costs, and frequencies of up to 60% have been reported <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref> .</s></p><p><s>The exact mechanism leading to new-onset POAF remains uncertain.</s><s>In addition to surgery-associated factors (like inflammation, oxidative stress and increased sympathetic drive), preexisting factors, including ion channel alterations, interstitial impairments, myocardial apoptosis and fibrosis, may provide pathophysiological substrates of POAF <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24]</ref> .</s></p><p><s>Despite the well-known arrhythmogenic potential of iodothyronines, their role for the pathogenesis of POAF is less well understood.</s><s>Two trials unexpectedly revealed low preoperative FT 3 concentrations and subclinical hypothyroidism to predict POAF <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref> .</s><s>However, experimental substitution therapy with TH in order to prevent POAF resulted in conflicting results <ref type="bibr" target="#b26">[27]</ref> .</s></p><p><s>In this prospective study we assessed the frequency of new-onset POAF in a series of patients who underwent cardiac surgery.</s><s>TACT, concentrations of B-type natriuretic peptide (BNP), serum apoptosis markers and iodothyronine metabolites were measured preoperatively in all patients.</s><s>We hypothesized that preoperative markers for thyroid status predict the risk for development of POAF.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Design of the Investigation and Patient Population</head><p><s>This cohort covers a subset of the population of a previous trial that evaluated the prognostic value of TACT for the onset of POAF <ref type="bibr" target="#b23">[24]</ref> .</s><s>After approval by the local institutional ethics committee on human study of the Ruhr University of Bochum (Bochum, Germany) we prospectively enrolled 39 noncritically ill patients who underwent cardiac surgery (coronary artery bypass graft, CABG, and/or aortic valve replacement, AVR).</s></p><p><s>The inclusion criteria were: (1) preoperative sinus rhythm (SR), and (2) elective CABG and/or AVR.</s><s>The exclusion criteria were:</s></p><p><s>(1) any history of AF or atrial flutter; (2) moderate or severe mitral valve disease; (3) prior cardiac surgery; (4) poor echocardiographic imaging quality; (5) any history of thyroid disease; (6) concentrations of TSH or FT 4 outside their respective reference ranges; <ref type="bibr" target="#b6">(7)</ref> an insufficient amount of preoperative serum aliquots, and (8) any antiarrhythmic medication pre-or perioperatively with the exception of β-blocking agents and verapamil.</s><s>All patients had received iodinated radiocontrast agents in coronary angiography 3-5 weeks preoperatively.</s></p><p><s>The main outcome measure of the investigation was serum concentration of FT 3 in patients with and without POAF.</s><s>Secondary outcome measures were concentrations of other hormones involved in thyroid homeostasis (total and free T 4 , TSH), total T 3 and nonclassical TH [3,5-diiodothyronine (3,5-T 2 ), 3,3 ′ ,5 ′ -triiodothyronine (reverse, rT 3 ) and 3-iodothyronamine (3-T 1 AM)].</s><s>In order to get exploratory information on pathophysiological processes, derived parameters of thyroid homeostasis were calculated, including thyroid's secretory capacity (SPINA-GT), total deiodinase activity (SPINA-GD), FT 3 /rT 3 , 3,5-T 2 /FT 3 and 3,5-T 2 /rT 3 ratios <ref type="bibr">[3,</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref> (see online suppl.</s><s>methods for a detailed description; see www.karger.com/doi/10.1159/000381543</s><s>for all online suppl.</s><s>material).</s><s>Concentrations of serum BNP and Fas ligand were determined to serve as markers for myocardial remodeling and apoptosis.</s></p><p><s>Detection of POAF was based on documentation of AF episodes by continuous telemetry for the first 3 postoperative days followed by 7 days via Holter-ECG monitoring.</s><s>POAF was defined as any episode of AF lasting 30 s or longer.</s></p><p><s>A single expert cardiologist blinded to the results of echocardiography and laboratory investigations diagnosed POAF and performed transthoracic echocardiography in all patients 1 day before surgery.</s><s>All patients provided written informed consent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Preoperative Echocardiography and TACT</head><p><s>Transthoracic echocardiography was performed 1 day before surgery using a GE Vivid 7 echocardiograph device according to standards of the American Society of Echocardiography.</s><s>Maximal and minimal left-atrial volume (LAV max and LAV min ) were measured from the apical 4-chamber view in the ventricular end-systole just before opening or after closure of the mitral valve, respectively, via the single-plane area-length method.</s><s>Subsequently, LAV max was indexed for body surface area to provide the left-atrial volume index (LAVI).</s><s>Left atrial ejection fraction (LA-EF) was calculated as:</s></p><formula xml:id="formula_0">max min max - 1 0 0 % . LAV LAV LA EF LAV</formula><p><s>In order to estimate the TACT, the tissue Doppler imaging (PA-TDI) interval was assessed twice per patient by measuring the time interval between the onset of the P wave in lead II of the ECG to the peak A' wave of the lateral atrial wall on tissue Doppler tracing.</s><s>Both results were averaged to calculate the mean PA-TDI interval.</s><s>See the online supplementary methods section for information on additional cardiovascular parameters.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Blood Sampling and Laboratory Analysis</head><p><s>Fasting blood samples were obtained in the morning before the intake of medication 1 day presurgery.</s><s>After centrifugation (2,800 rpm, 20 min), serum aliquots were stored at -80 ° C until analyzed.</s></p><p><s>Concentrations of TSH, FT 4 , TT 4 , FT 3 , TT 3 and BNP were determined with a fully automated chemiluminescence-based system (DxI800, Beckman-Coulter, Krefeld, Germany).</s><s>Serum concentrations of Fas ligand (Fas) and TRAIL, both members of the tumor necrosis factor superfamily, were measured using commercially available ELISA kits (R&amp;D Systems, Minneapolis, Minn., USA).</s><s>Inter-and intra-assay coefficients of variation (CV) were &lt;10 and &lt;5%, respectively.</s></p><p><s>The 3,5-T 2 concentrations were detected in a single batch of assays with a novel antibody-based chemiluminescence immunoassay with a working range between 0.2 and 10 nmol/l (detection limit 0.2 n M ; intra-assay variation &lt;10%, interassay variation &lt;13%), as recently described <ref type="bibr" target="#b32">[33]</ref> .</s><s>The method to quantify 3-T 1 AM concentrations was modified from a previously published immunoassay <ref type="bibr" target="#b33">[34]</ref> (detection limit 0.93 n M ; intra-and interassay variation &lt;13%).</s><s>rT 3 concentrations were determined with a commercially available RIA (ZenTech RIAZEN Reverse T 3 ; Radim, Freiburg, Germany; detection limit 0.014 n M , intra-and interassay variation &lt;9%) according to the manufacturer's instructions.</s><s>The antibodybound radiolabelled tracer was counted in a gamma counter (1277 Gammamaster, LKB Wallac, Turku, Finland).</s><s>Intra-assay CV was 8.7%.</s><s>Analyses were performed in duplicates.</s><s>Results were excluded from further analysis if the CV exceeded 20%.</s><s>Patients were classified as presenting NTIS if they exhibited low-T 3 syndrome or low-T 4 syndrome, i.e. if concentrations of FT 3 , TT 3 or TT 4 were reduced below their respective reference ranges in the absence of thyroid disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>Depending on the class of analyzed data and possible direction of causality, distributions were compared with multivariable logistic regression, two-sample t test, Wilcoxon's rank sum test or χ 2 test.</s><s>For multivariable logistic regression, parameters were selected that differed between patients with and without POAF in an a priori t test with p &lt; 0.1.</s><s>Predictors that gave reason to expect multicollinearity (total TH and parameters calculated from TH) were not included in the logistic regression.</s><s>For each predictor the variance inflation factor (VIF) was calculated to deliver a measure for possible multicollinearity.</s><s>Where not otherwise specified, data are presented as the mean value ± standard error of the mean (SEM) for normally distributed continuous data, as the median (interquartile range) for nonnormally distributed data, or as percentages for count data.</s><s>p &lt; 0.05 was considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient Characteristics</head><p><s>Thirty-nine patients undergoing cardiac surgery were included in the analysis.</s><s>Their mean age was 67 ± 2 years, and 7 patients were women.</s><s>In the total group, 29 patients underwent CABG alone, 8 patients AVR and 2 patients CABG and AVR.</s><s>The basic clinical characteristics of the study population are reported separately for POAF and NTIS in table 1 .</s><s>There was no association between anthropometric measures, parameters of patient history and medication with POAF (see online suppl.</s><s>table 1).</s><s>Likewise, most variables were identical in patients with and without NTIS, apart from the fact that patients with NTIS were slightly older ( table 1 ).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Biomarkers for POAF</head><p><s>In all subjects serum concentrations of Fas were 76 ± 4.5 ng/l and significantly higher in patients with POAF versus patients who maintained SR ( table <ref type="table" target="#tab_1">2</ref> ).</s><s>In addition, the PA-TDI interval was significantly longer at baseline compared to patients who maintained SR.</s><s>In the total study population PA-TDI was 134.3 ± 3.3 ms.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Phenotype of NTIS</head><p><s>Nine of the 39 included patients demonstrated NTIS as defined by reduced concentrations of TT 3 or FT 3 , or of TT 4 .</s><s>Concentrations of 3,5-T 2 were 0.45 ± 0.04 nmol/l in all subjects, but significantly increased in patients with NTIS ( table 2 ; fig. <ref type="figure" target="#fig_0">1</ref> ).</s><s>As expected, patients with NTIS demonstrated a reduced SPINA-GD and FT 3 /rT 3 ratio, but also an increased 3,5-T 2 /FT 3 ratio ( table 2 ).</s><s>Unlike age, no association of NTIS with sex, underlying disease, 3-T 1 AM concentration, CRP or creatinine was observed.</s></p><p><s>The total population showed a significant negative correlation between concentrations of FT 3 and 3,5-T 2 , but a positive correlation between 3,5-T 2 and rT 3 ( fig. <ref type="figure" target="#fig_1">2</ref> ).</s><s>SPINA-GD inversely correlated with 3,5-T 2 concentra-</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NTIS and Its Association with Atrial Remodeling and Transduction</head><p><s>LAVI was 29.1 ± 1.9 ml/m 2 in the overall group, was not different between patients who eventually developed POAF and those who did not, but was significantly elevated in patients with NTIS ( table 2 ).</s><s>No differences were observed with respect to LA-EF and LV-EF.</s><s>Concentrations of FT 3 and TT 3 as well as calculated deiodinase activity inversely correlated with the PA-TDI interval (online suppl.</s><s>fig. <ref type="figure" target="#fig_1">1, 2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>POAF and Thyroid Function</head><p><s>Seven out of the 17 patients (41%) who eventually developed POAF demonstrated NTIS prior to surgery, as compared to 2 of the 22 patients (9%) who remained in SR (p &lt; 0.05).</s><s>In patients with POAF, serum concentrations of FT 3 were significantly decreased and 3,5-T 2 concentrations were increased at baseline ( table <ref type="table" target="#tab_1">2</ref> ).</s><s>In addition, the SPINA-GD and FT 3 /rT 3 ratios were decreased, while the 3,5-T 2 /FT 3 ratio was increased compared to the group of patients who maintained SR ( table <ref type="table" target="#tab_1">2</ref> ).</s></p><p><s>In the model of multivariable logistic regression, FT 3 and 3,5-T 2 were independent predictors of POAF, together with the PA-TDI interval, LAVI and Fas ( table <ref type="table" target="#tab_2">3</ref> ).</s><s>VIF values suggested low multicollinearity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this study we analyzed the association between preoperative thyroid status, TACT and the development of POAF.</s><s>The main findings were: (1) patients who develop POAF have decreased basal FT 3 concentrations and increased 3,5-T 2 concentrations; (2) preoperative reduced FT 3 concentrations reflect markers of impaired outcome, first of all age and PA-TDI interval; (3) basal 3,5-T 2 concentrations positively correlate with rT 3 concentrations but inversely correlate with FT 3 , and (4) preoperative NTIS is associated with increased atrial remodeling and increased 3,5-T 2 concentrations.</s></p><p><s>Thyromimetic actions at cardiomyocytes, mainly attributed to T 3 , are able to destabilize the heart rhythm.</s><s>This effect results from upregulation of β1-adrenoceptors by TH <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref> , direct actions at cardiac potassium <ref type="bibr" target="#b36">[37]</ref> and sodium channels <ref type="bibr" target="#b37">[38]</ref> , hypermetabolism and a plethora of other mechanisms <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b38">39]</ref> .</s><s>It is therefore not astonishing that hyperthyroidism, even in its subclinical form, facilitates the development of AF <ref type="bibr" target="#b16">[17]</ref> .</s></p><p><s>In this cohort, however, we observed decreased FT 3 concentrations to be associated with AF, similar to a small number of previous reports <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref> .</s><s>FT 3 concentrations and SPINA-GD activity inversely correlated with age and PA-TDI interval, two markers of impaired prognosis.</s><s>Thus, the most plausible explanation for these associations might be that the more severely ill patients, presenting a mild form of NTIS, are faced with increased risk of POAF.</s><s>This assumption is also supported by the fact that patients with NTIS were not only older, but also presented significantly higher LAVI, suggesting left atrial remod-  eling.</s><s>However, even after correction for these confounders in multiple logistic regression, reduced FT 3 levels remained a predictor for POAF.</s><s>Unlike FT 3 , concentrations of 3,5-T 2 , an active TH metabolite and suggested product of 5 ′ -deiodination of T 3 , were significantly increased in the NTIS group.</s><s>Additionally, 3,5-T 2 positively correlates with rT 3 concentrations and inversely correlated with T 3 concentrations.</s><s>Serum concentrations of 3,5-T 2 were significantly elevated in patients who eventually developed POAF.</s><s>Increased 3,5-T 2 concentrations have been previously described in patients with liver cirrhosis and brain tumors <ref type="bibr" target="#b39">[40]</ref> .</s><s>However, to the best of our knowledge, this is the first study to describe elevated 3,5-T 2 concentrations in cardiac disease.</s></p><p><s>These results suggest that elevated 3,5-T 2 concentrations are part of the metabolic signature of NTIS.</s><s>However, interpretation of these findings on a mechanistic basis is not straightforward.</s><s>Recently, nonlinear associations of serum 3,5-T 2 concentrations with altered microvascular damage parameters and glucose metabolism were observed in a subpopulation of the Study of Health in Pomerania (SHIP-2 and SHIP-Trend) <ref type="bibr" target="#b40">[41,</ref><ref type="bibr">42]</ref> .</s></p><p><s>Usually, it is assumed that low-T 3 syndrome results from decreased phenolic ring 5 ′ -deiodination of T 4 to T 3 , mainly resulting from downregulated type 1 deiodinase (D1) <ref type="bibr" target="#b43">[43]</ref> .</s><s>Since PTU-sensitive D1 has been proposed to catalyze the conversion of T 3 to 3,5-T 2 in vivo <ref type="bibr" target="#b44">[44]</ref><ref type="bibr" target="#b45">[45]</ref><ref type="bibr" target="#b46">[46]</ref><ref type="bibr" target="#b47">[47]</ref> , one may suggest that plasma concentrations of the 3,5-T 2 should also be decreased in NTIS and not increased as observed in this cohort.</s><s>A possible explanation of these unexpected results could be that deiodination rates generating T 3 and its sequential product 3,5-T 2 differ and/or that their deiodination occurs in different tissues to a variant extent.</s><s>In cells, where D1 activity is downregulated deiodination of T 3 may stop at the T 3 stage, while it may be upregulated in tissues that form 3,5-T 2 .</s><s>This hypothesis requires the assumption of additional transport and control mechanisms that determine both the rate and local extent of deiodination.</s><s>In addition to impaired 5 ′ -deiodination of T 4 to T 3 , enhanced inactivation of T 4 by type 3 deiodinase (D3) generating rT 3 has also been observed in the liver and various other cells activated during inflammation and infection <ref type="bibr" target="#b1">[2]</ref> .</s><s>This combination might explain in part the shift of the T 3 /T 4 and T 3 /rT 3 ratios observed in NTIS.</s><s>However, elevated D3 activity in combination with decarboxylation would also degrade 3,5-T 2 to 3-T 1 AM, although in this study, we did not observe changes in 3-T 1 AM serum concentrations.</s><s>The serum TH metabolite profile observed in NTIS might be further influenced by tissue-specific uptake or efflux of TH metabolites <ref type="bibr">[1,</ref><ref type="bibr" target="#b48">48]</ref> in addition to altered deiodinase activities.</s></p><p><s>It could be hypothesized that POAF might result from increased 3,5-T 2 concentrations in the more severely ill patients.</s><s>However, in multivariable logistic regression, i.e. after correction for other explanatory variables including FT 3 , LAVI, PA-TDI and Fas, 3,5-T 2 was a negative predictor of POAF.</s><s>This suggests a complex interaction of multiple factors predisposing for POAF ( fig. <ref type="figure" target="#fig_2">3</ref> ) and 'high-3,5-T 2 syndrome' not to be the cause but a consequence of other, still to be identified factors in the pathogenesis of NTIS.</s><s>Since VIF is low for all parameters, the results are not explained by multicollinearity.</s></p><p><s>This investigation is faced with certain limitations.</s><s>First of all, its pure observational design limits possible causal attributions.</s><s>The limited number of included patients, a consequence of strict inclusion and exclusion criteria, may result in low statistical power.</s><s>Calculated parameters like SPINA-GD or the FT 3 /rT 3 ratio may provide valuable physiological insights, as they did in previous trials on NTIS <ref type="bibr">[30-32, 49, 50]</ref> , but they are also faced with limitations, since hormone concentrations also depend on tissue distribution and elimination.</s><s>Therefore, future interventional trials with enhanced methodology and a larger number of included patients are necessary to provide more details on these associations or cause-effect relationships involved in NTIS and POAF.</s><s>Elevated 3,5-T 2 serum concentration in combination with reduced FT 3 may represent a new, potentially clinically relevant predictive marker in cardiac illness.</s><s>3,5-T 2 might be a valuable indicator of T 3 metabolism, and its elevations in NTIS could explain why patients with low-T 3 syndrome substituted with T 4 /T 3 do not benefit from exogenous TH administration.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Distribution of preoperative 3,5-T 2 concentrations in patients with and without POAF ( a ) and with and without NTIS ( b ).</s><s>* p &lt; 0.05.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2.Correlation of preoperative concentrations of 3,5-T 2 with those of FT 3 (Spearman's rho -0.38, R 2 = 0.13, p &lt; 0.05; a ) and rT 3 (Spearman's rho 0.30, R 2 = 0.12, p &lt; 0.05; b ) in patients who developed POAF and those who maintained SR, respectively.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>aFig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Relation between age, TACT and preoperative concentrations of FT 3 ( a ) or 3,5-T 2 ( b ) and POAF.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Clinical characteristics of the study population Data are reported as n or mean ± SEM. * Significant after correction for multiple testing.</s><s>See online supplementary table 1 for additional, nonsignificant parameters.</s><s>n.s.</s><s>= Not significant.</s></p></div></figDesc><table><row><cell></cell><cell>Without POAF</cell><cell>With POAF</cell><cell>p</cell><cell>Without NTIS</cell><cell>With NTIS</cell><cell>p</cell></row><row><cell></cell><cell>(n = 22)</cell><cell>(n = 17)</cell><cell>value</cell><cell>(n = 30)</cell><cell>(n = 9)</cell><cell>value</cell></row><row><cell>Age, years</cell><cell>64.5 ± 2.4</cell><cell>69.5 ± 2.6</cell><cell>n.s.</cell><cell>64.8 ± 2.2</cell><cell>72.9 ± 1.5</cell><cell>&lt;0.01*</cell></row><row><cell>Sex</cell><cell></cell><cell></cell><cell>n.s.</cell><cell></cell><cell></cell><cell>n.s.</cell></row><row><cell>Female</cell><cell>3</cell><cell>4</cell><cell></cell><cell>7</cell><cell>0</cell><cell></cell></row><row><cell>Male</cell><cell>19</cell><cell>13</cell><cell></cell><cell>23</cell><cell>9</cell><cell></cell></row><row><cell>Body surface area, m 2</cell><cell>2.0 ± 0.0</cell><cell>2.0 ± 0.1</cell><cell>n.s.</cell><cell>2.0 ± 0.0</cell><cell>2.1 ± 0.1</cell><cell>n.s.</cell></row><row><cell>Body mass index</cell><cell>28.9 ± 0.7</cell><cell>28.7 ± 1.4</cell><cell>n.s.</cell><cell>28.7 ± 0.8</cell><cell>27.7 ± 1.8</cell><cell>n.s.</cell></row><row><cell>Operative parameters</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>CABG</cell><cell>17</cell><cell>12</cell><cell>n.s.</cell><cell>22</cell><cell>7</cell><cell>n.s.</cell></row><row><cell>AVR</cell><cell>5</cell><cell>3</cell><cell>n.s.</cell><cell>7</cell><cell>1</cell><cell>n.s.</cell></row><row><cell>CABG and AVR</cell><cell>0</cell><cell>2</cell><cell>n.s.</cell><cell>1</cell><cell>1</cell><cell>n.s.</cell></row><row><cell>Duration of surgery, min</cell><cell>211 ± 20</cell><cell>192 ± 23</cell><cell>n.s.</cell><cell>203 ± 16</cell><cell>209 ± 63</cell><cell>n.s.</cell></row><row><cell>Aortic cross clamp time, min</cell><cell>63 ± 9</cell><cell>9 7 ± 19</cell><cell>n.s.</cell><cell>79 ± 12</cell><cell>65 ± 14</cell><cell>n.s.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Echocardiographic, procedural characteristics and results of preoperative blood samples in the study population comparing subjects with and without POAF and with and without NTIS Data are reported as mean ± SEM.</s><s>Reference ranges are reported where available.</s><s>* Significant after correction for multiple testing.</s><s>See online supplementary table 1 for additional, nonsignificant parameters.</s><s>n.s.</s><s>= Not significant.</s></p></div></figDesc><table><row><cell>Parameter (reference range [51 -53])</cell><cell>Without POAF</cell><cell>POAF</cell><cell>p value</cell><cell>Without NTIS</cell><cell>NTIS</cell><cell>p value</cell></row><row><cell></cell><cell>(n = 22)</cell><cell>(n = 17)</cell><cell></cell><cell>(n = 30)</cell><cell>(n = 9)</cell><cell></cell></row><row><cell cols="2">Preoperative transthoracic echocardiogram</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>LA-EF, %</cell><cell>53.2 ± 3.6</cell><cell>45.3 ± 2.2</cell><cell>n.s.</cell><cell>48.9 ± 2.9</cell><cell>52.8 ± 2.7</cell><cell>n.s.</cell></row><row><cell>LAVI, ml/m 2</cell><cell>25.9 ± 2.3</cell><cell>33.2 ± 3.0</cell><cell>n.s.</cell><cell>26.6 ± 2.1</cell><cell>37.4 ± 2.9</cell><cell>&lt;0.01*</cell></row><row><cell>PA-TDI interval (&lt;152), ms</cell><cell>120.3 ± 2.3</cell><cell>152.5 ± 3.6</cell><cell>&lt;1e-7*</cell><cell>130.9 ± 3.5</cell><cell>145.7 ± 7.3</cell><cell>n.s.</cell></row><row><cell>Preoperative laboratory parameters</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Fas, ng/l</cell><cell>66.2 ± 3.6</cell><cell>90 ± 7.0</cell><cell>&lt;0.05</cell><cell>76.3 ± 5.4</cell><cell>74.7 ± 5.2</cell><cell>n.s.</cell></row><row><cell>TSH (0.4 -4.3), mIU/l</cell><cell>1.10 ± 0.13</cell><cell>1.46 ± 0.19</cell><cell>n.s.</cell><cell>1.23 ± 0.14</cell><cell>1.35 ± 0.22</cell><cell>n.s.</cell></row><row><cell>FT 4 (7.6 -16.1), pmol/l</cell><cell>11.7 ± 0.4</cell><cell>11.7 ± 0.3</cell><cell>n.s.</cell><cell>11.5 ± 0.2</cell><cell>12.3 ± 0.8</cell><cell>n.s.</cell></row><row><cell>FT 3 (4.0 -5.7), pmol/l</cell><cell>5.0 ± 0.2</cell><cell>4.4 ± 0.1</cell><cell>&lt;0.01*</cell><cell>5.0 ± 0.1</cell><cell>3.9 ± 0.1</cell><cell>&lt;1e-5*</cell></row><row><cell>TT 4 (64 -154), nmol/l</cell><cell>105 ± 3</cell><cell>104 ± 4</cell><cell>n.s.</cell><cell>101 ± 3</cell><cell>115 ± 3</cell><cell>&lt;0.05*</cell></row><row><cell>TT 3 (1.1 -2.8), nmol/l</cell><cell>1.80 ± 0.09</cell><cell>1.53 ± 0.11</cell><cell>n.s.</cell><cell>1.80 ± 0.07</cell><cell>1.32 ± 0.15</cell><cell>&lt;0.05*</cell></row><row><cell>rT 3 (0.14 -0.54), nmol/l</cell><cell>0.46 ± 0.02</cell><cell>0.50 ± 0.04</cell><cell>n.s.</cell><cell>0.47 ± 0.02</cell><cell>0.52 ± 0.03</cell><cell>n.s.</cell></row><row><cell>3,5-T 2 (0.20 -0.37), nmol/l</cell><cell>0.37 ± 0.04</cell><cell>0.53 ± 0.06</cell><cell>&lt;0.05</cell><cell>0.39 ± 0.04</cell><cell>0.59 ± 0.07</cell><cell>&lt;0.05*</cell></row><row><cell>3-T 1 AM, nmol/l</cell><cell>14.5 ± 0.7</cell><cell>14.5 ± 0.9</cell><cell>n.s.</cell><cell>14.2 ± 0.5</cell><cell>15.5 ± 1.8</cell><cell>n.s.</cell></row><row><cell>Calculated parameters</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SPINA-GT (1.4 -8.7), pmol/s</cell><cell>3.7 ± 0.3</cell><cell>3.1 ± 0.3</cell><cell>n.s.</cell><cell>3.5 ± 0.3</cell><cell>3.3 ± 0.5</cell><cell>n.s.</cell></row><row><cell>SPINA-GD (20 -60), nmol/s</cell><cell>40.6 ± 1.7</cell><cell>35.1 ± 1.6</cell><cell>&lt;0.05</cell><cell>40.6 ± 1.3</cell><cell>30.3 ± 1.8</cell><cell>&lt;0.001*</cell></row><row><cell>FT 3 /rT 3</cell><cell>11.8 ± 0.9</cell><cell>8.7 ± 0.6</cell><cell>&lt;0.05</cell><cell>11.5 ± 0.7</cell><cell>7.9 ± 0.6</cell><cell>&lt;0.001*</cell></row><row><cell>3,5-T 2 /FT 3</cell><cell>0.08 ± 0.01</cell><cell>0.13 ± 0.02</cell><cell>&lt;0.05</cell><cell>0.08 ± 0.01</cell><cell>0.15 ± 0.02</cell><cell>&lt;0.01*</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Model of multiple logistic regression analysis with respect to the risk of POAF</s></p></div></figDesc><table><row><cell></cell><cell>B</cell><cell>SE</cell><cell>Wald</cell><cell>d.f.</cell><cell>p value</cell><cell>OR (95% CI)</cell><cell>VIF</cell></row><row><cell>PA-TDI interval</cell><cell>2.361</cell><cell>0.040</cell><cell>3,562.0</cell><cell>1</cell><cell>&lt;1e-12</cell><cell>10.6 (9.8 to 11.4)</cell><cell>1.15</cell></row><row><cell>LAVI</cell><cell>-0.217</cell><cell>0.030</cell><cell>51.3</cell><cell>1</cell><cell>&lt;1e-4</cell><cell>0.81 (0.76 to 0.85)</cell><cell>1.16</cell></row><row><cell>FT 3</cell><cell>-5.935</cell><cell>0.571</cell><cell>107.9</cell><cell>1</cell><cell>&lt;1e-5</cell><cell>2.6e-3 (8.6e-4 to 8.1e-3)</cell><cell>1.11</cell></row><row><cell>3,5-T 2</cell><cell>-43.150</cell><cell>3.075</cell><cell>196.9</cell><cell>1</cell><cell>&lt;1e-8</cell><cell cols="2">1.8e-19 (4.4e-22 to 7.5e-17) 1.86</cell></row><row><cell>Fas</cell><cell>1.563</cell><cell>0.037</cell><cell>1,760.0</cell><cell>1</cell><cell>&lt;1e-10</cell><cell>4.78 (4.44 to 5.14)</cell><cell>1.80</cell></row><row><cell cols="4">Variables were chosen by a priori selection, as described.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Eur Thyroid J 2015;4:129-137 DOI: 10.1159/000381543</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure Statement</head><p><s>All authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Non-thyroidal illness in the ICU: a syndrome with different faces</title>
		<author>
			<persName><forename type="first">G</forename><surname>Den Berghe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1456" to="1465" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Beyond low plasma T 3 : local thyroid hormone metabolism during inflammation and infection</title>
		<author>
			<persName><forename type="first">A</forename><surname>Boelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kwakkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fliers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="670" to="693" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">TSH and thyrotropic agonists: key actors in thyroid homeostasis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Landgrafe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Fotiadou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Thyroid Res</title>
		<imprint>
			<biblScope unit="volume">2012</biblScope>
			<biblScope unit="page">351864</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Low-T 3 syndrome: a strong prognostic predictor of death in patients with heart disease</title>
		<author>
			<persName><forename type="first">G</forename><surname>Iervasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pingitore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Landi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Raciti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ripoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scarlattini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>'abbate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Donato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="708" to="713" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Klemperer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ojamaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Helm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">W</forename><surname>Isom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Krieger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="1323" to="1329" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Glucoseinsulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Ranasinghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Faroqui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Keogh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mascaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Riddington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Rooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Townend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Bonser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="I245" to="I250" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Does perioperative thyroxine have a role during adult cardiac surgery?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ronald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dunning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Interact Cardiovasc Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="166" to="178" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat?</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Utiger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page" from="1562" to="1563" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Dangerous dogmas in medicine: the nonthyroidal illness syndrome</title>
		<author>
			<persName><forename type="first">De</forename><surname>Groot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="151" to="164" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Comment on dangerous dogmas in medicine: the nonthyroidal illness syndrome</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Caplan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="2262" to="2263" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Concentrations of free thyroxin and albumin in serum in severe nonthyroidal illness: assay artefacts and physiological influences</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Midgley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Sheehan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Christofides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Fry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Browning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mardell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="765" to="771" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Non-thyroidal illness syndrome and shortterm survival in a hospitalised older population</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tognini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Marchini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dardano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Polini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ferdeghini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Castiglioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Monzani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Age Ageing</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="46" to="50" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Thyroid disease and the heart</title>
		<author>
			<persName><forename type="first">I</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Danzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="1725" to="1735" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Mechanisms in endocrinology: heart failure and thyroid dysfunction</title>
		<author>
			<persName><forename type="first">B</forename><surname>Biondi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="609" to="618" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Thyroid hormone action in the heart</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Kahaly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Dillmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="704" to="728" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Thyroid storm</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dietrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Klin Intensivmed Notfmed</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="448" to="453" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism</title>
		<author>
			<persName><forename type="first">T</forename><surname>Vadiveloo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Donnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cochrane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Leese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="1344" to="1351" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The effect of antithyroid treatment on atrial conduction times in patients with subclinical hyperthyroidism</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Nacar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Acar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yorgun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Akcay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ozkaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Canpolat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Akkoyun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tuncer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Echocardiography</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="950" to="955" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Increased preoperative serum apoptosis marker Fas ligand correlates with histopathology and new-onset of atrial fibrillation in patients after cardiac surgery</title>
		<author>
			<persName><forename type="first">P</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Deneke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schiedat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bösche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Strauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tannapfel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stiegler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mügge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ewers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1110" to="1115" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery</title>
		<author>
			<persName><forename type="first">J</forename><surname>Auer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Berent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Eber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Surg (Torino)</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="583" to="588" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Puskas JD: New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>El-Chami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kilgo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Thourani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Lattouf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Delurgio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Guyton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Leon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1370" to="1376" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients)</title>
		<author>
			<persName><forename type="first">A</forename><surname>Saxena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Dinh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Shardey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Newcomb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="219" to="225" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Schotten U: Post-operative atrial fibrillation: a maze of mechanisms</title>
		<author>
			<persName><forename type="first">B</forename><surname>Maesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Maessen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Allessie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Europace</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="159" to="174" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Correlation between total atrial conduction time estimated via tissue Doppler imaging (PA-TDI interval), structural atrial remodeling and new-onset of atrial fibrillation after cardiac surgery</title>
		<author>
			<persName><forename type="first">P</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hars</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schiedat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Bösche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gotzmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Strauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tannapfel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Deneke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mügge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ewers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="626" to="631" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Free triiodothyronine: a novel predictor of postoperative atrial fibrillation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Cerillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bevilacqua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Storti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mariani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kallushi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ripoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Clerico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Glauber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="487" to="492" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Subclinical hypothyroidism might increase the risk of transient atrial fibrillation after coronary artery bypass grafting</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">I</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Choh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Y</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="1846" to="1852" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Clinical review: thyroid hormone therapy for postoperative nonthyroidal illnesses: a systematic review and synthesis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Kaptein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Beale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="4526" to="4534" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">SPINA-THYR: a novel systems theoretic approach to determine the secretion capacity of the thyroid gland</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pantke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gärtner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Pickardt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Intern Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">S34</biblScope>
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>suppl</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The AQUA-FONTIS Study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stachon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Antic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hering</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Endocr Disord</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">13</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Tissue thyroid hormone levels in critical illness</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Peeters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Der Geyten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Wouters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Darras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Toor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kaptein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Van Den Berghe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="6498" to="6507" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Van den Berghe G: Serum 3,3 ′ ,5 ′ -triiodothyronine (rT 3 ) and 3,5,3 ′ -triiodothyronine/rT 3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Peeters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Wouters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Toor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kaptein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Visser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="4559" to="4565" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Heredity and lifestyle in the determination of between-subject variation in thyroid hormone levels in euthyroid men</title>
		<author>
			<persName><forename type="first">G</forename><surname>Roef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Taes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Toye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goemaere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fiers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Verstraete</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kaufman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="835" to="844" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Detection of 3,5-diiodothyronine in sera of patients with altered thyroid status using a new monoclonal antibody-based chemiluminescence immunoassay</title>
		<author>
			<persName><forename type="first">I</forename><surname>Lehmphul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Brabant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wallaschofski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruchala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Strasburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Köhrle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1350" to="1360" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Hoefig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Köhrle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Brabant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dixit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Yap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Strasburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="1864" to="1872" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Amiodarone decreases cardiac beta-adrenoceptors through an antagonistic effect on 3,5,3 ′ triiodothyronine</title>
		<author>
			<persName><forename type="first">G</forename><surname>Perret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nicolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pussard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vassy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Uzzan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berdeaux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Pharmacol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="473" to="478" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Thyroid hormones transcriptionally regulate the β1-adrenergic receptor gene in cultured ventricular myocytes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Bahouth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">266</biblScope>
			<biblScope unit="page" from="15863" to="15869" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Effects of thyroid hormone on the cardiovascular system</title>
		<author>
			<persName><forename type="first">S</forename><surname>Fazio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Palmieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Biondi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Recent Prog Horm Res</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="31" to="50" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Acute effects of thyroid hormone on sodium currents in neonatal myocytes</title>
		<author>
			<persName><forename type="first">W</forename><surname>Craelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Harris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biosci Rep</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="309" to="315" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">The mechanisms of atrial fibrillation in hyperthyroidism</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bielecka-Dabrowa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Mikhailidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rysz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Banach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid Res</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">4</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors</title>
		<author>
			<persName><forename type="first">G</forename><surname>Pinna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Meinhold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hiedra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Thoma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hoell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Graf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stoltenburg-Didinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Eravci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Prengel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Brodel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Finke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baumgartner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="1535" to="1542" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">High serum thyrotropin levels are associated with retinal arteriolar narrowing in the general population</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ittermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dörr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Völzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lehmphul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Köhrle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jürgens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1473" to="1478" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">5-T 2 Is Elevated in Nonthyroidal Cardiac Illness</title>
		<idno type="DOI">10.1159/000381543</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Thyroid J</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="129" to="137" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Translating pharmacological findings from hypothyroid rodents to euthyroid humans: is there a functional role of endogenous 3,5-T 2 ?</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pietzner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lehmphul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Friedrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schurmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ittermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dörr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Laqua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Volker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Brabant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Völzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Köhrle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Homuth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wallaschofski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="188" to="197" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination</title>
		<author>
			<persName><forename type="first">J</forename><surname>Köhrle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Best Pract Res Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="173" to="191" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Rapid stimulation of hepatic oxygen consumption by 3,5-di-iodo-L -thyronine</title>
		<author>
			<persName><forename type="first">C</forename><surname>Horst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rokos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Seitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">261</biblScope>
			<biblScope unit="page" from="945" to="950" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">5-T 2 stimulates oxygen consumption, but not glucose uptake in human mononuclear blood cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kvetny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="322" to="325" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Demonstration of in vivo metabolic effects of 3,5-di-iodothyronine</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cimmino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Minaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Geloen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="319" to="325" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-L -thyronine and by 3,3 ′ -diiodo-L -thyronine</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="89" to="94" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Expression of thyroid hormone transporters during critical illness</title>
		<author>
			<persName><forename type="first">L</forename><surname>Mebis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Paletta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Debaveye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ellger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Langouche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'hoore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Darras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Visser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Van Den Berghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="243" to="250" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Nonthyroidal illness syndrome: is it far away from Crohn&apos;s disease?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="153" to="159" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">The influence of body mass index and lowgrade systemic inflammation on thyroid hormone abnormalities in patients with type 2 diabetes</title>
		<author>
			<persName><forename type="first">Moura</forename><surname>Neto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Parisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Tambascia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Alegre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Pavin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Zantut-Wittmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr J</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="877" to="884" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Thyroid hormone reference intervals and the prevalence of thyroid antibodies</title>
		<author>
			<persName><forename type="first">C</forename><surname>Cavusoglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bilgili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ö</forename><surname>Erkizan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Arican</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Karaca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Turk J Med Sci</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="665" to="672" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Comparison of three free T 4 (FT 4 ) and free T 3 (FT 3 ) immunoassays in healthy subjects and patients with thyroid diseases and severe nonthyroidal illnesses</title>
		<author>
			<persName><forename type="first">C</forename><surname>Fillee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cumps</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Ketelslegers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Lab</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="725" to="736" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Total atrial conduction time assessed by tissue Doppler imaging (PA-TDI interval) to predict early recurrence of persistent atrial fibrillation after successful electrical cardioversion</title>
		<author>
			<persName><forename type="first">P</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schiedat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bialek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bösche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ewers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mügge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Deneke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="161" to="167" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
